APA (7th ed.) Citation

Badamasi, I. M., Yusuf, A. A., Abubakar, I. S., Bala, J. A., Aliyu, I. A., Salman, J., . . . Kabir, I. (2024). A Pilot Study for Drug-Resistant Tuberculosis Disease Patients Suggests that A964G (rs153109)—Interleukin 27 may be Protective. Nigerian Journal of Basic & Clinical Sciences, 21(2), 103. https://doi.org/10.4103/njbcs.njbcs_88_23

Chicago Style (17th ed.) Citation

Badamasi, Ibrahim Mohammed, Abdullahi Asuku Yusuf, Isa Sadeeq Abubakar, Jamilu Abubakar Bala, Isah Abubakar Aliyu, Julius Salman, Kolawole Salami, and Imam-Malik Kabir. "A Pilot Study for Drug-Resistant Tuberculosis Disease Patients Suggests That A964G (rs153109)—Interleukin 27 May Be Protective." Nigerian Journal of Basic & Clinical Sciences 21, no. 2 (2024): 103. https://doi.org/10.4103/njbcs.njbcs_88_23.

MLA (9th ed.) Citation

Badamasi, Ibrahim Mohammed, et al. "A Pilot Study for Drug-Resistant Tuberculosis Disease Patients Suggests That A964G (rs153109)—Interleukin 27 May Be Protective." Nigerian Journal of Basic & Clinical Sciences, vol. 21, no. 2, 2024, p. 103, https://doi.org/10.4103/njbcs.njbcs_88_23.